Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02012361 · ClinicalTrials.gov registry record · Phase 1
Inspired Helium for Ischemic Protection During Knee Replacement Surgery
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT02012361 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 40 participants.
The verdict
NCT02012361, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether breathing in helium reduces indications of injury to the skeletal muscle seen in blood tests after knee replacement surgery. The ability to reduce the risk of skeletal muscle injury may help improve patient safety by providing protection to the area of the body having its blood supply interrupted during a particular surgery.
Interventions
- PROCEDURE Muscle Biopsy
- PROCEDURE Control Group
- PROCEDURE Single-Dose Heliox Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02012361
The ClinicalTrials.gov registry entry for NCT02012361 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Muscle Biopsy is the first listed.
NCT02012361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02012361 about?
NCT02012361 is a clinical study titled "Inspired Helium for Ischemic Protection During Knee Replacement Surgery". The purpose of this study is to determine whether breathing in helium reduces indications of injury to the skeletal muscle seen in blood tests after knee replacement surgery. The ability to reduce the risk of skeletal muscle injury may help improve patient safety by providing protection to the area...
What is the current status of trial NCT02012361?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2014-10. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02012361?
The interventions under investigation include: Muscle Biopsy (PROCEDURE), Control Group (PROCEDURE), Single-Dose Heliox Group (PROCEDURE).
Who is sponsoring clinical trial NCT02012361?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.